Celastrol Alleviates Intestinal Epithelial Permeability by Inhibiting Ferroptosis through PI3K/Akt/FOXO1/HO-1 Signaling Pathway
The American Journal of Chinese Medicine · 2025-01 · 53 (04) · 1207-1224
DOI: 10.1142/s0192415x25500466 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Chinese Medicine, online erschienen am 30.06.2025. Verfasst von Dan Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Key Laboratory of Target-Based Drug Discovery and Research, University of Technology Chongqing 400054, China. Hauptthemen laut MEDLINE: Intestinal Mucosa, Signal Transduction, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Natural Scientific Fund of Chongqing Science and Technology Bureau.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a recurrent inflammatory intestinal disorder characterized by systemic inflammatory response, abnormal intestinal epithelial cell death, and damage to the intestinal mucosal barrier. This study aimed to explore the role of celastrol in ferroptosis and intestinal epithelial barrier permeability. The results demonstrated that celastrol significantly inhibited ferroptosis in RSL3-induced intestinal epithelial cells by regulating the expression of ferroptosis-related proteins. Concurrently, celastrol dramatically improved the permeability of the intestinal epithelial monolayer by increasing the expression of tight junction proteins including ZO-1, occludin, and claudin-1. Moreover, celastrol markedly attenuated the effect of RSL3 on the phosphorylation of Akt and FOXO1. LY294002, a PI3K inhibitor, significantly inhibited the role of celastrol in the expression of ferroptosis-related and intestinal tight junction proteins. In vivo, celastrol administration not only significantly ameliorated dextran sulfate sodium (DSS)-induced colitis by preventing neutrophil infiltration, but also ameliorated intestinal mucosa damage, and colon shortening. Celastrol administration was also found to reduce the expression of ferroptosis-related proteins prevent the infiltration of fluorescein isothiocyanate-dextran (FITC-dextran) and increase the levels of tight junction proteins. Collectively, these findings suggest that due to its effects on ferroptosis and tight junctions in intestinal epithelial cells, celastrol may be a compound with significant promise in the prevention and treatment of UC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chongqing Key Laboratory of Target-Based Drug Discovery and Research, University of Technology Chongqing 400054, China.
- Department of Gastroenterology, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing 401147, China.
- Chongqing Academy of Chinese Materia Medica, Chongqing University of Chinese Medicine, Chongqing 400065, China.
- College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China.
ORCID-Profile: Dan Wu, Ping Shi, Lian-Hua Tang, Xiao-Mei Song, Juan Deng, Hong Guo, Fei Yin
Förderung
- Natural Scientific Fund of Chongqing Science and Technology Bureau
Zitieren
APA
Wu, D., Shi, P., Tang, L. H., Song, X. M., Deng, J., Guo, H., & Yin, F. (2025). Celastrol Alleviates Intestinal Epithelial Permeability by Inhibiting Ferroptosis through PI3K/Akt/FOXO1/HO-1 Signaling Pathway. The American Journal of Chinese Medicine, 53(04), 1207-1224. https://doi.org/10.1142/s0192415x25500466
Vancouver
Wu D, Shi P, Tang LH, Song XM, Deng J, Guo H, et al. Celastrol Alleviates Intestinal Epithelial Permeability by Inhibiting Ferroptosis through PI3K/Akt/FOXO1/HO-1 Signaling Pathway. The American Journal of Chinese Medicine. 2025;53(04):1207-1224. doi:10.1142/s0192415x25500466
BibTeX
@article{Wu2025,
author = {Wu, Dan and Shi, Ping and Tang, Lian-Hua and Song, Xiao-Mei and Deng, Juan and Guo, Hong and Yin, Fei},
title = {Celastrol Alleviates Intestinal Epithelial Permeability by Inhibiting Ferroptosis through PI3K/Akt/FOXO1/HO-1 Signaling Pathway},
journal = {The American Journal of Chinese Medicine},
year = {2025},
volume = {53},
number = {04},
pages = {1207--1224},
doi = {10.1142/s0192415x25500466}
}
EUVIMED